Andrew J Foy
Overview
Explore the profile of Andrew J Foy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
343
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao J, Ruzieh M, Du F, Lian Y, Foy A, Platt R, et al.
Circ Cardiovasc Qual Outcomes
. 2025 Mar;
:e011188.
PMID: 40026152
Background: Previous observational studies showed left atrial appendage occlusions with the WATCHMAN device reduced 1-year mortality, which conflicted with evidence generated from randomized controlled trials. We proposed to use the...
2.
Ruzieh M, Mandrola J, Foy A
Am Heart J Plus
. 2025 Feb;
50:100497.
PMID: 40008274
No abstract available.
3.
4.
Filippone E, Foy A, Naccarelli G
Am Heart J Plus
. 2024 Apr;
12:100065.
PMID: 38559601
Hypertension remains a leading cause of morbidity and mortality. Recent treatment guidelines stress more strict systolic blood pressure (SBP) targets without regard for abnormally low achieved diastolic blood pressures (DBP)....
5.
Sayed A, Ross J, Mandrola J, Lehmann L, Foy A
JAMA
. 2024 Mar;
331(15):1325-1327.
PMID: 38546577
No abstract available.
6.
Foy A, Schaefer E, Ruzieh M, Nudy M, Ali O, Chinchilli V, et al.
Am J Med
. 2024 Feb;
137(7):608-616.e3.
PMID: 38331136
Objective: The purpose of this study was to examine the multimorbidity burden of clinical trial participants and assess its association with treatment response. Methods: We conducted a reanalysis of patient...
7.
Filippone E, Naccarelli G, Foy A
Am J Med
. 2023 Oct;
137(1):12-22.
PMID: 37832756
Apparent resistant hypertension, defined as uncontrolled office blood pressure despite ≥ 3 antihypertensive medications including a diuretic or use of ≥ 4 medications regardless of blood pressure, occurs in ≤...
8.
Foy A, Vrana K, Haidet P, Hausman B, Adams N, Ropson I, et al.
Adv Med Educ Pract
. 2023 Sep;
14:989-998.
PMID: 37724185
Purpose: Critical thinking and the ability to engage with others of differing views in a civil manner is essential to the practice of medicine. A new format for medical student...
9.
Filippone E, Naccarelli G, Foy A
Am J Med
. 2023 May;
136(9):857-868.
PMID: 37230403
Renal denervation is not a cure for hypertension. Although more recent sham-controlled trials were positive, a significant minority of patients in each trial were unresponsive. The optimal patient or patients...
10.
Ahmed M, Nudy M, Bussa R, Filippone E, Foy A
Eur J Intern Med
. 2023 May;
113:83-90.
PMID: 37150718
Introduction: There is a lack of consensus regarding the best add on therapy for treatment of resistant hypertension (RH). This is likely secondary to a paucity of data on the...